[1]程珍,吴宙光,叶泳钦.胆道闭锁无创诊断现状与研究进展[J].临床小儿外科杂志,2021,20(08):785-790.[doi:10.12260/lcxewkzz.2021.08.015]
　Cheng Zhen,Wu Zhouguang,Ye Yongqin.Recent advances in noninvasive diagnosis of biliary atresia in early stage[J].Journal of Clinical Pediatric Surgery,2021,20(08):785-790.[doi:10.12260/lcxewkzz.2021.08.015]
点击复制

胆道闭锁无创诊断现状与研究进展

《临床小儿外科杂志》[ISSN:1671-6353/CN:43-1380/R] 卷: 第20卷 期数: 2021年08期 页码: 785-790 栏目: 综述 出版日期: 2021-08-10
Title:
Recent advances in noninvasive diagnosis of biliary atresia in early stage
作者:
程珍1;  吴宙光2;  叶泳钦2
1. 中国医科大学深圳市儿童医院普外科(广东省深圳市, 518026);
2. 深圳市儿童医院普外科(广东省深圳市, 518026)
Author(s):
Cheng Zhen1;  Wu Zhouguang2;  Ye Yongqin2
1. Department of General Surgery, Shenzhen Children’s Hospital, China Medical University, Shenzhen 518026, China;
2. Department of General Surgery, Municipal Children’s Hospital, Shenzhen, 518026, China
关键词:
胆道闭锁; 早期诊断; 无创; 综述
Keywords:
Biliary Atresia; Early Diagnosis; Noninvasiveness; Review
分类号:
R726.574.4;R726.1
DOI:
10.12260/lcxewkzz.2021.08.015
摘要:
胆道闭锁（biliary atresia，BA）是新生儿梗阻性黄疸的常见原因，其病理特征为肝外或肝内胆管的炎症及进行性肝纤维化。如能早期诊断，可显著减少并发症，改善患者预后。因此BA的早期诊断极为重要。目前BA诊断的金标准是术中胆道造影及肝组织病理活检，该诊断方法有创，且常需高年资医生作出判断。寻找灵敏度、特异度高，无创，可定量的早期诊断方法尤为迫切。本文围绕大便比色卡，粪便、尿液、血液来源标记物及影像学检查等无创诊断方法的研究进展进行综述，以期为临床诊疗工作提供参考。
Abstract:
As a common cause of neonatal obstructive jaundice, biliary atresia (BA) is characterized by inflammation and progressive fibrosis of extrahepatic or intrahepatic bile ducts. An early diagnosis may significantly improve the prognosis of children and lower the incidence of complications. Therefore an early diagnosis of BA is particularly important. Currently the gold standards for diagnosing BA are intraoperative cholangiography and liver pathological biopsy. Such a diagnostic mode is invasive and often requires the judgment of senior doctors. Thus it is imperative to seek a non-invasive and quantitative tool with high sensitivity and specificity. This review summarized the latest researches in the diagnostic efficacy of BA through stool colorimetric cards, stool, urine, blood-derived markers and imaging studies to provide rationales for clinical diagnosis and treatment.

参考文献/References:

1 Wang J, Xu Y, Chen Z, et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia[J]. Cell, 2020, 183(7):1867-1883.e26. DOI:10.1016/j.cell.2020.10.048.
2 Wang KS, Section S, Committee F, et al. Newborn screening for biliary atresia[J]. Pediatrics, 2015, 136(6):e1663-e1669. DOI:10.1542/peds.2015-3570.
3 Matsui A, Ishikawa T.Identification of infants with biliary atresia in Japan[J]. Lancet, 1994, 343(8902):925. DOI:10.1016/s0140-6736(94)90052-3.
4 Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan[J]. Pediatrics, 2006, 117(4):1147-1154. DOI:10.1542/peds.2005-1267.
5 Zheng J, Ye Y, Wang B, et al. Biliary atresia screening in Shenzhen:implementation and achievements[J]. Arch Dis Child, 2020, 105(8):720-723. DOI:10.1136/archdischild-2019-317787.
6 Franciscovich A, Vaidya D, Doyle J, et al. PoopMD, a mobile health application, accurately identifies infant acholic stools[J]. Plos One, 2015, 10(7):e0132270. DOI:10.1371/journal. pone.0132270.
7 Hoshino E, Hayashi K, Suzuki M, et al. An iPhone application using a novel stool color detection algorithm for biliary atresia screening[J]. Pediatric Surgery International, 2017, 33(10):1115-1121. DOI:10.1007/s00383-017-4146-8.
8 Gu YH, Yokoyama K, Mizuta K, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival:a 19-year cohort study in Japan[J]. J Pediatr, 2015, 166(4):897-902.e891. DOI:10.1016/j.jpeds.2014.12.063.
9 Molinaro A, Wahlstrom A, Marschall HU.Role of bile acids in metabolic control[J]. Trends Endocrinol Metab, 2018, 29(1):31-41. DOI:10.1016/j.tem.2017.11.002.
10 Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis[J]. J Hepatol, 2013, 58(5):949-955. DOI:10.1016/j.jhep.2013.01.003.
11 Wang J, Qian T, Jiang J, et al. Gut microbial profile in biliary atresia:a case-control study[J]. J Gastroenterol Hepatol, 2020, 35(2):334-342. DOI:10.1111/jgh.14777.
12 Shinka T, Inoue Y, Ohse M, et al. Simple and quantitative analysis of urinary sulfated tauro-and glycodihydroxycholic acids in infant with cholestasis by electrospray ionization mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 855(1):104-108. DOI:10.1016/j.jchromb.2007.04.010.
13 El-Guindi MA, El-Said HH, Hussein MH, et al. Urinary urobilinogen in biliary atresia:A missed, simple and cheap diagnostic test[J]. Hepatol Res, 2016, 46(2):174-182. DOI:10.1111/hepr.12558.
14 Suzuki M, Muraji T, Obatake M, et al. Urinary sulfated bile acid analysis for the early detection of biliary atresia in infants[J]. Pediatr Int, 2011, 53(4):497-500. DOI:10.1111/j.1442-200X.2010.03268.x.
15 Li WW, Yang Y, Dai QG, et al. Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome[J]. Metabolomics, 2018, 14(7):90. DOI:10.1007/s11306-018-1387-z.
16 Powell JE, Keffler S, Kelly DA, et al. Population screening for neonatal liver disease:potential for a community-based programme[J]. J Med Screen, 2003, 10(3):112-116. DOI:10.1177/096914130301000303.
17 沈中阳, 夏强, 詹江华.胆道闭锁诊断及治疗指南(2018版)[J]. 中华小儿外科杂志, 2019, 35(11):2435-2440. DOI:10.3969/j.issn.1001-5256.2019.11.009. Shen ZY, Xia Q, Zhan JH.Guidelines for Diagnosing and Treating Biliary Atresia (2018 Edition)[J]. Chin J Ped Surg, 2019, 35(11):2435-2440. DOI:10.3969/j.issn.1001-5256.2019.11.009.
18 Harpavat S, Garcia-Prats JA, Anaya C, et al. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements[J]. JAMA, 2020, 323(12):1141-1150. DOI:10.1001/jama.2020.0837.
19 Chen X, Dong R, Shen Z, et al. Value of gamma-glutamyl transpeptidase for diagnosis of biliary atresia by correlation with age[J]. J Pediatr Gastroenterol Nutr, 2016, 63(3):370-373. DOI:10.1097/MPG.0000000000001168.
20 El-Guindi MA, Sira MM, Sira AM, et al. Design and validation of a diagnostic score for biliary atresia[J]. J Hepatol, 2014, 61(1):116-123. DOI:10.1016/j.jhep.2014.03.016.
21 Rendon-Macias ME, Villasis-Keever MA, Castaneda-Mucino G, et al. Improvement in accuracy of gamma-glutamyl transferase for differential diagnosis of biliary atresia by correlation with age[J]. Turk J Pediatr, 2008, 50(3):253-259.
22 Russo P, Magee JC, Anders RA, et al. Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome:a multicenter study[J]. Am J Surg Pathol, 2016, 40(12):1601-1615. DOI:10.1097/PAS.0000000000000755.
23 Dong R, Jiang J, Zhang S, et al. Development and validation of novel diagnostic models for biliary atresia in a large cohort of chinese patients[J]. EBioMedicine, 2018, 34:223-230. DOI:10.1016/j.ebiom.2018.07.025.
24 Lertudomphonwanit C, Mourya R, Fei L, et al. Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia[J]. Sci Transl Med, 2017, 9(417):eaan8462. DOI:10.1126/scitranslmed.aan8462.
25 Wu JF, Jeng YM, Chen HL, et al. Quantification of serum matrix metallopeptide 7 levels may assist in the diagnosis and predict the outcome for patients with biliary atresia[J]. J Pediatr, 2019, 208:30-37.e1. DOI:10.1016/j.jpeds.2018.12.006.
26 Jiang J, Wang J, Shen Z, et al. Serum MMP-7 in the diagnosis of biliary atresia[J]. Pediatrics, 2019, 144(5):e20190902. DOI:10.1542/peds.2019-0902.
27 Honsawek S, Praianantathavorn K, Chongsrisawat V, et al. High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia[J]. Pediatr Surg Int, 2011, 27(7):681-687. DOI:10.1007/s00383-010-2816-x.
28 Nadler EP, Patterson D, Violette S, et al. Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia[J]. J Surg Res, 2009, 154(1):21-29. DOI:10.1016/j.jss.2008.05.023.
29 Zahm AM, Hand NJ, Boateng LA, et al. Circulating microRNA is a biomarker of biliary atresia[J]. Journal of Pediatric Gastroenterology and Nutrition, 2012, 55(4):366-369. DOI:10.1097/MPG.0b013e318264e648.
30 Dong R, Shen Z, Zheng C, et al. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia[J]. Sci Rep, 2016, 6:21084. DOI:10.1038/srep21084.
31 Peng X, Yang L, Liu H, et al. Identification of circulating MicroRNAs in biliary atresia by next-generation sequencing[J]. J Pediatr Gastroenterol Nutr, 2016, 63(5):518-523. DOI:10.1097/MPG.0000000000001194.
32 Olaizola P, Lee-Law PY, Arbelaiz A, et al. MicroRNAs and extracellular vesicles in cholangiopathies[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B):1293-1307. DOI:10.1016/j.bbadis.2017.06.026.
33 Esparza-Baquer A, Labiano I, Bujanda L, et al. MicroRNAs in cholangiopathies:Potential diagnostic and therapeutic tools[J]. Clin Res Hepatol Gastroenterol, 2016, 40(1):15-27. DOI:10.1016/j.clinre.2015.10.001.
34 Xiao Y, Liu R, Li X, et al. Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia[J]. Hepatology, 2019, 70(5):1658-1673. DOI:10.1002/hep.30698.
35 Nuerzhati Y, Dong R, Song Z, et al. Role of the long noncoding RNAAnnexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresia associated hepatic injury[J]. Int J Mol Med, 2019, 43(2):739-748. DOI:10.3892/ijmm.2018.4023.
36 Zhou L, Shan Q, Tian W, et al. Ultrasound for the diagnosis of biliary atresia:a Meta-analysis[J]. AJR Am J Roentgenol, 2016, 206(5):W73-W82. DOI:10.2214/AJR.15.15336.
37 Takamizawa S, Zaima A, Muraji T, et al. Can biliary atresia be diagnosed by ultrasonography alone?[J]. J Pediatr Surg, 2007, 42(12):2093-2096. DOI:10.1016/j.jpedsurg.2007.08.032.
38 Endo K, Yoshida M, Yokoi A.Triangular cord sign on ultrasonography does not indicate disease progression of biliary atresia[J]. Indian J Pediatr, 2019, 86(7):656-657. DOI:10.1007/s12098-019-02967-8.
39 Weng Z, Zhou L, Wu Q, et al. Enlarged hepatic hilar lymph node:an additional ultrasonographic feature that may be helpful in the diagnosis of biliary atresia[J]. Eur Radiol, 2019, 29(12):6699-6707. DOI:10.1007/s00330-019-06339-w.
40 Wu JF, Lee CS, Lin WH, et al. Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy[J]. Hepatology, 2018, 68(2):616-624. DOI:10.1002/hep.29856.
41 沈秋龙, 陈亚军, 彭春辉, 等.肝脏硬度测量值预测胆道闭锁术后五年自体肝生存的价值研究[J]. 临床小儿外科杂志, 2020, 19(6):486-490, 512. DOI:10.3969/j.issn.1671-6353.2020.06.005. Shen QL, Chen YJ, Peng CH, et al. Value of liver hardness measurement in predicting 5-year survival of autogenous liver after biliary atresia[J]. J Clin Ped Sur, 2020, 19(6):486-490, 512. DOI:10.3969/j.issn.1671-6353.2020.06.005.
42 Hanquinet S, Courvoisier DS, Rougemont AL, et al. Acoustic radiation force impulse sonography in assessing children with biliary atresia for liver transplantation[J]. Pediatr Radiol, 2016, 46(7):1011-1016. DOI:10.1007/s00247-016-3565-3.
43 Dillman JR, Dipaola FW, Smith SJ, et al. Prospective assessment of ultrasound shear wave elastography for discriminating biliary atresia from other causes of neonatal cholestasis[J]. J Pediatr, 2019, 212:60-65.e63. DOI:10.1016/j.jpeds.2019.05.048.
44 Duan X, Peng Y, Liu W, et al. Does Supersonic shear wave elastography help differentiate biliary atresia from other causes of cholestatic hepatitis in infants less than 90 days old? compared with grey-scale US[J]. Biomed Res Int, 2019, 2019:9036362. DOI:10.1155/2019/9036362.
45 李娜, 盛长青.SWE辅助超声诊断胆道闭锁患者的应用价值[J]. 现代消化及介入诊疗, 2019, 24(11):1351-1353, 1357. DOI:10.3969/j.issn.1672-2159.2019.11.034. Li N, Sheng CQ.Application value of SWE assisted ultrasound in the diagnosis of children with biliary atresia[J]. Modern Digestion & Intervention, 2019, 24(11), 1351-1353, 1357. DOI:10.3969/j.issn.1672-2159.2019.11.034.
46 Wang Y, Xie X, Cao Q, et al. Quantitative contrast-enhanced ultrasound by sonazoid in the early diagnosis of biliary atresia:an experimental study of rats with bile duct ligation[J]. Ultrasound Med Biol, 2019, 45(10):2767-2776. DOI:10.1016/j.ultrasmedbio.2019.06.409.
47 Feldman AG, Mack CL.Biliary atresia:clinical lessons learned[J]. J Pediatr Gastroenterol Nutr, 2015, 61(2):167-175. DOI:10.1097/MPG.0000000000000755.

相似文献/References:

[1]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[3]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
　[J].Journal of Clinical Pediatric Surgery,2012,11(08):187.
[4]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[5]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[6]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[7]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[8]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[9]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.
[10]张震 李龙 乔国梁. 胆道闭锁Kasai术后生存率及条件生存率分析[J].临床小儿外科杂志,2015,14(01):25.
[11]刘坤慧,龚一鸣,蔡威.Nomogram模型用于胆道闭锁早期诊断的效能验证[J].临床小儿外科杂志,2023,22(03):211.[doi:10.3760/cma.j.cn101785-202207050-003]
　Liu Kunhui,Gong Yiming,Cai Wei.Efficacy verification of Nomogram tool for an early diagnosis of biliary atresia[J].Journal of Clinical Pediatric Surgery,2023,22(08):211.[doi:10.3760/cma.j.cn101785-202207050-003]

备注/Memo

收稿日期:2020-07-25。
基金项目:2018年度深圳市医疗卫生三名工程（编号：SZSM201812055）
通讯作者:吴宙光,Email:guang99b3@163.com

更新日期/Last Update: 1900-01-01